Material Detail

Enhancing Decision Making within the Life Sciences through the use of Semantic Technologies

Enhancing Decision Making within the Life Sciences through the use of Semantic Technologies

This video was recorded at 3rd Annual European Semantic Technology Conference (ESTC), Vienna 2009. Bringing new drugs to market is hard. It requires understanding how novel compounds will influence disease across heterogeneous populations. It also requires the demonstration of comparative effectiveness of therapies, the minimization of safety related risk, and meeting global regulatory requirements. In order to spur innovation, companies are exploring the adoption of new business models, which include bringing fresh ideas into organizations through collaboration, and enhancing product development through tightening the connection between drug discovery and the clinical environment. This presentation will describe how Semantic Web technologies can benefit companies in light of new business models, and will provide examples as to how Semantic Web technology is currently being used within Johnson and Johnson.

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.